Status:
COMPLETED
Effects of Tradipitant on Satiation, Gastric Volume, Gastric Accommodation, and Gastric Emptying in Healthy Volunteers
Lead Sponsor:
Vanda Pharmaceuticals
Collaborating Sponsors:
Mayo Clinic
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
To evaluate the effects of tradipitant relative to placebo on satiation, gastric volume, gastric accommodation, and gastric emptying in healthy volunteers.
Eligibility Criteria
Inclusion
- Able to provide written consent
- Body Mass Index (BMI) of 18-35 kg/m2
- No medical problems or chronic diseases
Exclusion
- Diagnosis of gastrointestinal diseases
- Structural or metabolic diseases that affect the GI system
- A positive test for drugs of abuse at screening
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2021
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT04849559
Start Date
February 1 2021
End Date
September 24 2021
Last Update
April 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanda Investigational Site
Rochester, Minnesota, United States, 55905